Table 3.
Numerical results of ADO production from pooled MV.
| MM patients |
MGUS/SMM patients |
|||
|---|---|---|---|---|
| 15 min | 45 min | 15 min | 45 min | |
| (A) Substrate: ATP (nmol) | ||||
| ATP | 74.8 | 54.4 | 84.3 | 78.3 |
| AMP | 19.5 | 40 | 9.5 | 17.3 |
| ADO | 0.8 | 1.5 | 0.4 | 0.6 |
| (B) Substrate: AMP (nmol) | ||||
| AMP | 43.9 | 20.6 | 57.8 | 47.4 |
| ADO | 33.2 | 47.4 | 24.1 | 29.6 |
| (C) Substrate: ADPR (nmol) | ||||
| ADPR | 83.8 | 79.1 | 83.4 | 79.5 |
| AMP | 11.1 | 10.6 | 10 | 8.5 |
| ADO | 1.2 | 1.5 | 0.6 | 1.2 |
| (D) Substrate: NAD+ (nmol) | ||||
| NAD+ | 18 | 17.6 | 40.9 | 38.2 |
| ADPR | 15.5 | 0 | 1.1 | 5.3 |
| Nic | 13.6 | 17.01 | 3.1 | 4.9 |
| ADO | 0.7 | 1.5 | 0.5 | 0.6 |